PURPOSE: The in vitro and in vivo effects of pyrvinium pamoate (PP), a newly identified WNT signaling inhibitor, were evaluated against colon cancer cell lines and primary colon cancer samples. EXPERIMENTAL DESIGN: Antiproliferative activity of PP and its effects on protein and RNA levels of WNT targets were evaluated on adenomatous polyposis coli (APC (mut)) and β-catenin(mut) cell lines, one WNT(wt) colon cancer cell line, as well as six primary colon cancer samples with mutant APC in vitro. In addition, the effect of PP on the growth of liver metastasis was examined. RESULTS: PP blocked colon cancer cell growth in vitro in a dose-dependent manner with great differences in the inhibitory concentration (IC(50)), ranging from 0.6 × 10(-6) to 65 × 10(-6) mol/L for colon cancer cells with mutations in WNT signaling. In addition, PP demonstrated a cytotoxic effect on primary colon cancer samples. A combined cytotoxic effect of PP with 5-fluorouracil (5-FU) was observed for two cell lines. PP decreased messenger RNA (mRNA) and protein levels of known WNT target genes as c-MYC and thereby led to the induction of p21. PP inhibited the migration of HCT116 colon cancer cells in vitro and decreased tumor growth in vivo after intraportal injection of HCT116 cells in nude mice. CONCLUSIONS: PP displays promising anticancer activity against a broad panel of human colon cancer cell lines, as well as primary colon cancer samples. However, our findings do not demonstrate a predominant cytotoxic effect of PP on colon cancer cells with mutations in WNT signaling.
PURPOSE: The in vitro and in vivo effects of pyrvinium pamoate (PP), a newly identified WNT signaling inhibitor, were evaluated against colon cancer cell lines and primary colon cancer samples. EXPERIMENTAL DESIGN: Antiproliferative activity of PP and its effects on protein and RNA levels of WNT targets were evaluated on adenomatous polyposis coli (APC (mut)) and β-catenin(mut) cell lines, one WNT(wt) colon cancer cell line, as well as six primary colon cancer samples with mutant APC in vitro. In addition, the effect of PP on the growth of liver metastasis was examined. RESULTS: PP blocked colon cancer cell growth in vitro in a dose-dependent manner with great differences in the inhibitory concentration (IC(50)), ranging from 0.6 × 10(-6) to 65 × 10(-6) mol/L for colon cancer cells with mutations in WNT signaling. In addition, PP demonstrated a cytotoxic effect on primary colon cancer samples. A combined cytotoxic effect of PP with 5-fluorouracil (5-FU) was observed for two cell lines. PP decreased messenger RNA (mRNA) and protein levels of known WNT target genes as c-MYC and thereby led to the induction of p21. PP inhibited the migration of HCT116 colon cancer cells in vitro and decreased tumor growth in vivo after intraportal injection of HCT116 cells in nude mice. CONCLUSIONS: PP displays promising anticancer activity against a broad panel of humancolon cancer cell lines, as well as primary colon cancer samples. However, our findings do not demonstrate a predominant cytotoxic effect of PP on colon cancer cells with mutations in WNT signaling.
Authors: Andreas Thalheimer; Doreen Korb; Lars Bönicke; Armin Wiegering; Bettina Mühling; Manuela Schneider; Silvia Koch; Simone S Riedel; Christoph Thomas Germer; Andreas Beilhack; Stephanie Brändlein; Christoph Otto Journal: J Surg Res Date: 2013-03-30 Impact factor: 2.192
Authors: Curtis A Thorne; Alison J Hanson; Judsen Schneider; Emilios Tahinci; Darren Orton; Christopher S Cselenyi; Kristin K Jernigan; Kelly C Meyers; Brian I Hang; Alex G Waterson; Kwangho Kim; Bruce Melancon; Victor P Ghidu; Gary A Sulikowski; Bonnie LaFleur; Adrian Salic; Laura A Lee; David M Miller; Ethan Lee Journal: Nat Chem Biol Date: 2010-10-03 Impact factor: 15.040
Authors: Donald R Senger; Carole A Perruzzi; Michael Streit; Victor E Koteliansky; Antonin R de Fougerolles; Michael Detmar Journal: Am J Pathol Date: 2002-01 Impact factor: 4.307
Authors: David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling Journal: Lancet Date: 2010-03-20 Impact factor: 79.321
Authors: Longfei Deng; Yunlong Lei; Rui Liu; Jingyi Li; Kefei Yuan; Yi Li; Yi Chen; Yi Liu; You Lu; Carl K Edwards; Canhua Huang; Yuquan Wei Journal: Cell Death Dis Date: 2013-05-02 Impact factor: 8.469
Authors: Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman Journal: Genome Biol Date: 2002-06-18 Impact factor: 13.583
Authors: Efrat Dotan; Dana B Cardin; Heinz-Josef Lenz; Wells Messersmith; Bert O'Neil; Steven J Cohen; Crystal S Denlinger; Safi Shahda; Igor Astsaturov; Ann M Kapoun; Rainer K Brachmann; Shailaja Uttamsingh; Robert J Stagg; Colin Weekes Journal: Clin Cancer Res Date: 2020-07-21 Impact factor: 12.531
Authors: C Otto; S Schmidt; C Kastner; S Denk; J Kettler; N Müller; C T Germer; E Wolf; P Gallant; A Wiegering Journal: Neoplasia Date: 2019-11-14 Impact factor: 5.715
Authors: Federica Laudisi; Martin Marônek; Antonio Di Grazia; Giovanni Monteleone; Carmine Stolfi Journal: Int J Mol Sci Date: 2020-07-13 Impact factor: 5.923
Authors: Sepideh Aminzadeh-Gohari; Daniela D Weber; Luca Catalano; René G Feichtinger; Barbara Kofler; Roland Lang Journal: Biomolecules Date: 2020-09-30